Pulmonary Embolism Prognosis Model
Observation Study of Clinical Manifestation and Outcome in Chinese Pulmonary Embolism
1 other identifier
observational
1,500
1 country
1
Brief Summary
The purpose of this study is to analyze the clinical manifestations, imaging features, and prognosis-related factors of pulmonary embolism, and to explore the prognosis risk assessment model for Chinese patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 24, 2020
CompletedStudy Start
First participant enrolled
June 1, 2020
CompletedFirst Posted
Study publicly available on registry
June 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedJune 2, 2020
May 1, 2020
3 years
May 24, 2020
May 28, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient survival time
Patient survival time after diagnosed as pulmonary embolism
Through study completion, an average of 4 year
Interventions
observation
Eligibility Criteria
Inpatients diagnosed as pulmonary embolism who meet the inclusion criteria above.
You may qualify if:
- Aged 18 years or older. Discharged with the diagnosis of PE from Peking Union Medical College Hospital.
You may not qualify if:
- Diagnosed PE by other health care facility or transferred from other health care facility .
- Without important follow-up data.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730, China
Biospecimen
serum
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Juhong Shi, M.D
Peking Union Medical College Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 24, 2020
First Posted
June 2, 2020
Study Start
June 1, 2020
Primary Completion
June 1, 2023
Study Completion
June 1, 2024
Last Updated
June 2, 2020
Record last verified: 2020-05